Abstract
The history of sexual medicine as a science is relatively new. This is no attempt to go back into ancient history to examine early practices for treating sexual disorders but starts with the modern era with the work of Masters and Johnson and Kinsey. It would be encyclopedic to include the details from all the contributors who have made this field now science but I have attempted to divide the topic in areas that have made this modern science and to include citations that have comprehensive reference sections that include major contributors. Each of the areas that I have divided this chapter could be a volume in itself. I know that by even doing this that I inadvertently have overlooked a few important contributors. There is a concentration on erectile dysfunction (ED) because from the days of vascular surgery there has been a tremendous explosion of anatomical, physiological, and molecular studies to examine the function of erection, both centrally and in the end organ and to define the pathophysiology of ED. But other sexual disorders in the male have been defined by science within the last 40 years. The focus on sexual disorders in women is relatively new, but it is truly become more scientific as well and I have tried to include references to some key papers that reflect that science. Since the mid-1970s the history has been intense and has led to logarithmic advances which, at best, are only partially discussed in this chapter. This chapter includes brief sections on psychotherapy history, vascular revascularization, penile prostheses, venous surgery, vacuum devices, epidemiology, diagnostic tools, intracavernosal injection therapy, oral therapy of ED, basic science, Peyronie’s disease, priapism, ejaculation problems, hormonal treatment and evaluation, and women’s disorders. I have tried to keep these in some order of when key studies evolved and show how the interaction of one area led to more scientific studies in the other area.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kinsey AC, Pomeroy WB, Martin CE, Gebhard PH. Sexual behavior in the human male. Philadelphia, PA: WB Saunders; 1948.
Masters WB, Johnson VE. The human sexual response. Boston: Little, Brown, and Co.; 1966.
Masters WB, Johnson VE. Human sexual inadequacy. Boston: Little, Brown, and Co.; 1970.
Kaplan HS. The new sexual therapy. New York: Brunner/Mazel; 1974.
Kaplan HS. Hypoactive sexual desire. J Sex Marital Ther 3(1):1977.
Kaplan HS. Disorders of sexual desires. New York: Brunner/Mazel; 1979.
Wagner G, Kaplan HS. The new injection treatment for impotence. New York: Brunner/Mazel; 1993.
Perelmann MA. Integrated sex therapy: a psychosocial-cultural perspective intergrading behavioral, cognitive, and medical approaches. In: Carson CC, Kirby RS, Goldstein I, Wyllie MG, editors. Textbook of erectile dysfunction. New York, NY: Informa Healthcare; 2009. p. 61–71.
Michal V, Viramar R, Pospichal J, Hejhal L. Arterial epigastricocavernous anastomosis for the treatment of sexual impotence. World J Surg. 1977;1:515–9.
Gineste JF, Romieu A. Radiologic exploration of impotence. The Hague, The Netherlands: Martinus Nijhoff; 1978.
Lewis RW, Wagner G. History of the International Society for Sexual Medicine (ISSM)—the beginnings. J Sex Med. 2008;5:740–5.
Lizza EF. History-Adrian Walton Zorgniotti (1925-1994): renaissance urologist. J Sex Med. 2005;2:272–7.
Zorgniotti AW and Rossi G, editors. Vasculogenic impotence. Proceedings of the first international conference on corpus cavernosum revascularization. Springfield, IL: Charles C. Thomas Publisher; 1980.
Mulcahy JJ. The development of modern penile implants. Sex Med Rev. 2016;4:177–89.
Multiple Authors. Contemporary review of historical papers in penile implant surgery. J Sex Med. 2015;12(Suppl 7):413–68.
Trost L, Hellstrom WJG. History, contemporary outcomes and future of penile prostheses: a review of the literature. Sex Med Rev. 2013;3:150–63.
Lewis RW. The international society for sexual medicine: a rich history and a bright future. Sex Med Rev. 2013;1:65–75.
Lewis RW. In: Paulson DF, editor. The pharmacologic erection in the impotent man: problems in urology. Philadelphia: J.P. Lippincott; 1991. p. 541–58.
Wagner G. The development of injection therapy. In: Wagner G, Kaplan HS, editors. The new injection treatment for impotence. New York: Brunner/Mazel; 1993. p. 18–29.
Zorgniotti A, Lefleur RS. Auto-injection of the corpus cavernosum with a vaso-active drug combination for vasculogenic impotence. J Urol. 1985;133:39–41.
Kunelius P, Lukkarinen O. Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction. Int J Impotence Res. 1999;11:21–4.
Porst H. Transurethral Alprostadil with MUSE™ (medicated urethral system for erection) vs intracavernous Alprostadil- a comparative study in 103 patients with erectile dysfunction. Int J Imptence Res. 1997;9:187–92.
Junemann KP, Alken P. Pharmacotherapy of erectile dysfunction: a review. Int J Impotence Res. 1989;1:71–93.
Belew D, Klassen Z, Lewis RW. Intracavernosal injection for the diagnosis, evaluation, and treatment of erectile dysfunction: a review. Sex Med Rev. 2015;3:11–23.
Lewis R, Puyau, Kerstein MD, Kaack MB. Corpus cavernosa outflow as defined by dynamic cavernosography. In: Ronald Virag, Helene Virag-Lappas, editors. Proceedings of the first world meeting on impotence. Paris: Les Editions du CERI; 1986. p. 138–42.
Lewis RW. Venous ligation surgery for venous leakage. Int J Impotence Res. 1990;2:1–19.
Rhee AC. Lewis RW. Vacuum systems for erectile dysfunction. In: Carson CC, Kirby RS, Goldstein I, Wyllie MG, editors. Textbook of erectile dysfunction. New York, NY: Informa Healthcare; 2009. p. 291–7.
Carrion R, Bochinski D, Rahman N, Lue TF. Physiology and pharmacology of erectile dysfunction. In: Broderick GA, editor. Oral pharmacotherapy for male sexual dysfunction. Totowa, NJ: Humana Press; 2003. p. 1–24.
deGroat WC, Steers WD. Neuroanatomy and neurophysiology of penile erection. In: Tanagho EA, Lue TF, McClure RD, editors. Contemporary management of impotence and infertility. Baltimore, MD: Williams and Wilkins; 1988. p. 3–27.
Carson CC, Kirby RS, Goldstein I, Wyllie MG. Textbook of erectile dysfunction. New York, NY: Informa Healthcare; 2009. p. 25–119.
Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010;7:1598–607.
McCabe MP, Sharlip ID, Atalla E, et al. Definitions of sexual dysfunction in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13:135–43.
McCabe MP, Sharlip ID, Lewis R, et al. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13:144–52.
McCabe MP, Sharlip ID, Lewis R, et al. Risk factors for sexual dysfunction among women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13:153–67.
Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, LIzza F, Martin A. Definitions, classification, and epidemiology of sexual dysfunction. In: Lue TF, Basson R, Rosen R, Giuliano F, and Khoury S, Montorsi F, editors. Sexual medicine: sexual dysfunction in men and women. Paris Health Publications; 2004. p. 39–72.
Lewis RW, Parulkar BG, Johnson CM, Miller WE. Radiology of impotence. In: Lytton B, Catalona WJ, Lipshultz LI, McGuire EJ, editors. Advances in urology, vol III. Chicago: Mosby Year Book, Inc.; 1990. p. 132–53.
Karacan I. Clinical value of nocturnal erection in the prognosis and diagnosis of impotence. Med Asp Hum Sex. 1970;4:27–34.
Bradley WE, Timm GW, Gallagher JM, Johnson BK. New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology. 1985;26:4–9.
Slob AK, Blom JHM, Van Der Werft Ten Bosch J. Erectile problems in medical practice: differential diagnosis with relatively simple method. J Urol. 1990;143:46–50.
Rowland DL, Den Ouden AH, Slob AK. The use of vibrotactile stimulation for determining sexual potency in the laboratory in men with erectile problems: methodological considerations. Int J Impotence Res. 1994:153–61.
Goldstein I. Vasculogenic impotence: its diagnosis and treatment. In: deVere White R, editor. Problems in urology. Philadelphia: Lippincott; 1987. p. 547–63.
Lue TF, Hrick H, Marich KW, Tanagho EA. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985;155:777–81.
Quam JP, King BF, James EM, Lewis RW, Brakke DM, Ilstrup DM, Parulkar BG, Hattery RR. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. Am J Roentgenol. 1989;153:1141–7.
Hattery RR, King BF, Lewis RW, McKusick M. Vasculogenic impotence: duplex and color Doppler imaging. Radiol Clin North Am. 1991;29(3):629–35.
King BF, Hattery RR, James FM, Lewis RW. Duplex sonography in the evaluation of impotence: current techniques. Semin Int Radiol. 1990;7(3–4):215–21.
Sikka SC, Hellstrom WJ, Brock G, Morales AM. Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med. 2013;10:120–9.
Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.
Rosen RC, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual dysfunction. J Sex Marital Ther. 2000;26:191–208.
Barrisford GW, O’Leary MP. Design, development, and use of questionnaires in the evaluation and management of erectile dysfunction. In: Carson CC, Kirby RS, Goldstein I, Wyllie MG, editors. Textbook of erectile dysfunction. New York, NY: Informa Healthcare; 2009. p. 347–52.
Padma-Nathan H. Sildenafil citrate, the classic PDE-5 inhibitor. In: Broderick GA, editor. Oral pharmacotherapy for male sexual dysfunction—a guide to clinical management, Totowa, NJ: Humana Press; 2003. p. 65–83.
Levine LA, Lenting EL. A surgical algorithm for the treatment of Peyronie’s disease. J Urol. 1997;158:2149–52.
Ralph D, Gonzalez-Cadavid N, Mirone V, et al. The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex Med. 2010;7:2359–74.
Yafi FA, April D, Powers MK, et al. Penile priapism, clitoral priapism, and persistent genital arousal disorder: a contemporary review. Sex Med Rev. 2015;3:145–59.
McMahon CG. Current and emerging treatments for premature ejaculation. Sex Med Rev. 2015;3:183–202.
Sadowski MD, Butcher J, Kohler TS. A review of pathophysiology and management options for delayed ejaculation. Sex Med Rev. 2016;4:167–76.
Mills TM, Lewis RW. The role of androgens in the maintenance of the erectile response: a 1999 perspective. Molecular Urology. 1999;3:75–80.
Maggi M, Corona G, Forti G. Endocrinolgy of male sexual function. In: Carson CC, Kirby RS, Goldstein I, Wyllie MG, editors. Textbook of erectile dysfunction. New York, NY: Informa Healthcare; 2009. p. 61–71.
Dean JD, McMahon CG, Guay AT, et al. The international society for sexual medicine’s process of care for the assessment and management of testosterone deficiency. J Sex Med. 2015;12:1660–86.
Corona G, Isidori AM, Aversa A, et al. Endocrinologic control of men’s sexual desire and arousal/erection. J Sex Med. 2016;13:317–37.
Marson L, Giamberardino MA, Constantini R, et al. Animal models for the study of female sexual dysfunction. Sex Med Rev. 2013;1:108–22.
Khera M. Testosterone therapy of female sexual dysfunction. Sex Med Rev. 2015;3:137–44.
Parish SJ, Hahn R. Hypoactive sexual desire disorder: a review of epidemiology, biopsychology, diagnosis, and treatment. Sex Med Rev. 2016;4:103–20.
Davis SR, Worsley R, Miller KK, et al. Androgens and female sexual dysfunction-findings from the fourth international consultation of sexual medicine. J Sex Med. 2016;13:168–78.
Worsley R, Santoro N, Miller KK, et al. Hormones and female sexual dysfunction: beyond estrogens and androgens—findings from the fourth international consultation on sexual medicine. J Sex Med. 2016;13:283–90.
Pukall CF, Goldstein AT, Bergeron S, et al. Vulvodynia: definition, prevalence, impact, and pathophysiological factors. J Sex Med. 2016;13:291–304.
Santoro N, Worsley R, Miller K, et al. Role of estrogens and estrogen-like compounds in female sexual dysfunction. J Sex Med. 2016;13:305–16.
Levin RJ, Both S, Georgiadis J, et al. The physiology of female sexual function and pathophysiology of female sexual dysfunction. J Sex Med. 2016;13:733–59.
Jayne C, Simon JA, Taylor LV, et al. Open-label extension study of Flipanserin in women with hypoactive sexual desire disorder. J Sex Med. 2012;9:3180–8.
Gao Z, Yang D, Yu L, Cui Y. Efficacy and safety of Flibanserin in women with hypoactive sexual disorder: a systematic review and meta-analysis. J Sex Med. 2015;12:2095–104.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Lewis, R.W. (2017). The History of Modern Sexual Medicine. In: IsHak, W. (eds) The Textbook of Clinical Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-52539-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-52539-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52538-9
Online ISBN: 978-3-319-52539-6
eBook Packages: MedicineMedicine (R0)